[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EP2429297A4 - Method of administering dose-sparing amounts of formoterol fumarate-budesonide combination particles by inhalation - Google Patents

Method of administering dose-sparing amounts of formoterol fumarate-budesonide combination particles by inhalation

Info

Publication number
EP2429297A4
EP2429297A4 EP10780911.3A EP10780911A EP2429297A4 EP 2429297 A4 EP2429297 A4 EP 2429297A4 EP 10780911 A EP10780911 A EP 10780911A EP 2429297 A4 EP2429297 A4 EP 2429297A4
Authority
EP
European Patent Office
Prior art keywords
inhalation
formoterol fumarate
budesonide
particles
combination particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP10780911.3A
Other languages
German (de)
French (fr)
Other versions
EP2429297A1 (en
Inventor
Robert O Cook
Guzman Veronica S De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MAP Pharmaceuticals Inc
Original Assignee
MAP Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MAP Pharmaceuticals Inc filed Critical MAP Pharmaceuticals Inc
Publication of EP2429297A1 publication Critical patent/EP2429297A1/en
Publication of EP2429297A4 publication Critical patent/EP2429297A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Disclosed are methods, and related compositions, that include administering a dose- sparing amount of a formulation that includes inhalation particles to a subject by inhalation; wherein the inhalation particles comprise formoterol fumarate and budesonide, the formoterol fumarate and budesonide being in a distributed encapsulated morphology with respect to one another within said inhalation particles and the formoterol fumarate being in a predetermined mass ratio with regard to the budesonide within said inhalation particles.
EP10780911.3A 2009-05-15 2010-05-14 Method of administering dose-sparing amounts of formoterol fumarate-budesonide combination particles by inhalation Withdrawn EP2429297A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21637109P 2009-05-15 2009-05-15
PCT/US2010/001436 WO2010138158A1 (en) 2009-05-15 2010-05-14 Method of administering dose-sparing amounts of formoterol fumarate-budesonide combination particles by inhalation

Publications (2)

Publication Number Publication Date
EP2429297A1 EP2429297A1 (en) 2012-03-21
EP2429297A4 true EP2429297A4 (en) 2013-12-25

Family

ID=43222995

Family Applications (1)

Application Number Title Priority Date Filing Date
EP10780911.3A Withdrawn EP2429297A4 (en) 2009-05-15 2010-05-14 Method of administering dose-sparing amounts of formoterol fumarate-budesonide combination particles by inhalation

Country Status (2)

Country Link
EP (1) EP2429297A4 (en)
WO (1) WO2010138158A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018071434A1 (en) * 2016-10-11 2018-04-19 Microdose Therapeutx, Inc. Inhaler and methods of use thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007011989A2 (en) * 2005-07-15 2007-01-25 Map Pharmaceuticals, Inc. Multiple active pharmaceutical ingredients combined in discrete inhalation particles and formulations thereof
WO2007009164A1 (en) * 2005-07-15 2007-01-25 Eiffel Technologies Limited Method of particle formation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6406745B1 (en) * 1999-06-07 2002-06-18 Nanosphere, Inc. Methods for coating particles and particles produced thereby
US20060257324A1 (en) * 2000-05-22 2006-11-16 Chiesi Farmaceutici S.P.A. Pharmaceutical solution formulations for pressurised metered dose inhalers

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007011989A2 (en) * 2005-07-15 2007-01-25 Map Pharmaceuticals, Inc. Multiple active pharmaceutical ingredients combined in discrete inhalation particles and formulations thereof
WO2007009164A1 (en) * 2005-07-15 2007-01-25 Eiffel Technologies Limited Method of particle formation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2010138158A1 *

Also Published As

Publication number Publication date
EP2429297A1 (en) 2012-03-21
WO2010138158A1 (en) 2010-12-02

Similar Documents

Publication Publication Date Title
MX2010010468A (en) Delivery particle.
MX2016008226A (en) Prebiotic oral care methods using a saccharide.
MX344238B (en) Tetrazole compounds and methods of making and using same.
MX364229B (en) COMPOSITIONS and METHODS FOR TREATING CARDIOVASCULAR DISEASES.
HK1220631A1 (en) Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same
MX2014002087A (en) Pyrethroid formulations.
MY161595A (en) Oral care compositions
WO2010084480A3 (en) Delivery particles
WO2010079467A3 (en) Delivery particles
TN2011000416A1 (en) Pharmaceutical composition comprising glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process for their preparation and uses thereof for improved glycemic control in a patient
IL222268A (en) Substituted pyrrolo-pyridines, pharmaceutical compositions comprising them, combined compositions comprising them and their use in the manufacture of medicaments
PH12014501158A1 (en) Composition comprising a shelf-life stability component
EP2646019A4 (en) Preparation and use of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane in the treatment of conditions affected by monoamine neurotransmitters
WO2012112321A3 (en) Dental compositions comprising mixture of isocyanurate monomer and tricyclodecane monomer
GB2511993A (en) Prebiotic formulations and methods of use
UA98839C2 (en) N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
NZ595985A (en) A novel formulation of naproxen
EP2370068A4 (en) Methods and compositions for delivery of medicaments to the lungs
WO2010106008A3 (en) Fungicidal compositions comprising fluopyram and metrafenone
MX2014004694A (en) Compositions.
MX336225B (en) Compositions comprising salbutamol sulphate.
MX2013009703A (en) Flavor pre-blends for chewing gum, methods of making flavor pre-blends and chewing gum compositions thereof.
MX2013002601A (en) Chewing gum compositions providing flavor release profiles.
MX2015009891A (en) Pharmaceutical compositions comprising multi-component crystalline particles suitable for use in inhalation therapy.
WO2012006585A3 (en) Use of interleukin-15 to treat cardiovascular diseases

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20111012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME RS

RIN1 Information on inventor provided before grant (corrected)

Inventor name: COOK, ROBERT O.

Inventor name: DE GUZMAN, VERONICA, S.

A4 Supplementary search report drawn up and despatched

Effective date: 20131127

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/72 20060101AFI20131121BHEP

Ipc: A61K 31/58 20060101ALI20131121BHEP

Ipc: A61K 31/167 20060101ALI20131121BHEP

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: MAP PHARMACEUTICALS INC

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20161201